SPRB

Conviction 4HealthcareScan · Thu, Sep 24, 2026

Hammer

Spruce Biosciences, Inc. (SPRB) closed at $49.27 (-0.29%) on Sep 24, 2026. Its latest daily candle is a hammer. Price is below its 50-day and below its 200-day moving average. RSI(14) 39, RS Rating 99, -73.0% from its 52-week high, -45.7% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

SPRB$49.27-0.29%

ResistanceSupportVol 14

Vol MA14 114.91K

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

SPRUCE BIOSCIENCES, INC.PHARMACEUTICAL PREPARATIONSwww.sprucebiosciences.com ↗

Price49.27

Change-0.29%

Gap-1.10%

Rel volume0.41×

Avg volume110.84K

Avg $ vol6.16M

SMA 2055.62

SMA 5051.03

SMA 20060.69

Price vs 50-3.45%

Price vs 200-18.82%

MA stackbearish

50/200 cross—

Supertrenddown · 58.87

RSI (14)39

MACD hist-1.14

MACD cross—

Stoch %K / %D27 / 21

ADX (14)22

+DI / −DI16 / 29

RSI divergence—

MACD divergence—

ATR %6.98%

ADR %5.86%

52w high182.60

52w low7.75

From 52w high-73.02%

Above 52w low+535.74%

New 52w highNo

SqueezeOff

Bollinger width26.33%

%B0.07

Donchian pos22.96%

Donchian high63.56

Donchian low45.01

AVWAP (52w high)94.99

vs AVWAP high-48.13%

AVWAP (52w low)102.58

vs AVWAP low-51.97%

OBV trendDown

Chaikin MF (20)-0.04

Today vs 20d0.41×

Avg vol (14d)114.91K

Avg vol (20d)110.84K

Avg $ vol (20d)6.16M

Market cap141.6M

RS Rating99 / 99

RS 3m (vs SPY)-11.12%

RS 6m (vs SPY)-46.40%

RS line new highNo

Trend template1/8

Technical rank17.9

1 week-8.52%

1 month-22.29%

3 months-6.63%

6 months-29.58%

1 year+479.65%

YTD-45.68%

P/E-3.63

P/B1.69

P/S—

P/FCF-4.25

EPS-50.83

Div yield—

ROE-46.54%

ROA-37.89%

Debt/Eq0.08

Current9.23

EV/EBITDA-1.44

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth26.53%

Price target158.60

Target upside221.90%

Analyst ratingBuy

Institutional75.53%

Ent. value52.4M

Revenue0

Net income-16.23M

Gross profit—

Free cash flow-33.33M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out2.75M

Employees8

ListedFri, Oct 9, 2020

Free float722.82K

Float %67.5%

Short interest440.24K

Days to cover6.0d

Short volume88.5%

Squeeze score85 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$6.68 vs −$4.79

Last surprise-39.5% miss

Setup gradeD

Conviction4 / 100

Pattern quality—

Tech rank17.9 / 100

Group rank59 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmHammer

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SPRB

All disclosures →

No recent disclosed trades by Congress in SPRB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SPRB

Insider	Side	Shares	Value	Traded	Filed
Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER · Common Stock · 2026-06-30	Grant	266	$1K	2026-06-30	2026-07-09
Walbert Keli Director · Stock Option (Right to Buy) · 2026-05-21	Grant	1.7K	$0	2026-05-21	2026-05-26
SIMPSON CAMILLA V Director · Stock Option (Right to Buy) · 2026-05-21	Grant	1.7K	$0	2026-05-21	2026-05-26
GREY MICHAEL G Executive Chairman · Stock Option (Right to Buy) · 2026-05-21	Grant	1.7K	$0	2026-05-21	2026-05-26
SPIEGELMAN DANIEL K Director · Stock Option (Right to Buy) · 2026-05-21	Grant	1.7K	$0	2026-05-21	2026-05-26
Barretto-Ko Percival Director · Stock Option (Right to Buy) · 2026-05-21	Grant	1.7K	$0	2026-05-21	2026-05-26

SEC filings

EDGAR filings in SPRB · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.